Literature DB >> 19954971

Coumarins as novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer.

Koichiro Harada1, Hideki Kubo, Yoshitaka Tomigahara, Kazuhiko Nishioka, Junya Takahashi, Mio Momose, Shinichi Inoue, Atsuyuki Kojima.   

Abstract

The synthesis and SAR studies of 3- and 4-substituted 7-hydroxycoumarins as novel 17beta-HSD3 inhibitors are discussed. The most potent compounds from this series exhibited low nanomolar inhibitory activity with acceptable selectivity versus other 17beta-HSD isoenzymes and nuclear receptors. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954971     DOI: 10.1016/j.bmcl.2009.10.111

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.

Authors:  Mirja Rotinen; Joaquín Villar; Ignacio Encío
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

Review 2.  Design and synthesis of hybrid compounds as novel drugs and medicines.

Authors:  Abdulaziz H Alkhzem; Timothy J Woodman; Ian S Blagbrough
Journal:  RSC Adv       Date:  2022-07-06       Impact factor: 4.036

3.  Palladium-catalyzed substitution of (coumarinyl)methyl acetates with C-, N-, and S-nucleophiles.

Authors:  Kalicharan Chattopadhyay; Erik Fenster; Alexander J Grenning; Jon A Tunge
Journal:  Beilstein J Org Chem       Date:  2012-07-27       Impact factor: 2.883

Review 4.  Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy.

Authors:  Inna Armandari; Agus Rizal Hamid; Gerald Verhaegh; Jack Schalken
Journal:  Prostate Int       Date:  2014-08-21

5.  QSAR Study of 17β-HSD3 Inhibitors by Genetic Algorithm-Support Vector Machine as a Target Receptor for the Treatment of Prostate Cancer.

Authors:  Eslam Pourbasheer; Saadat Vahdani; Davood Malekzadeh; Reza Aalizadeh; Amin Ebadi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 6.  Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.

Authors:  Angela Stefanachi; Francesco Leonetti; Leonardo Pisani; Marco Catto; Angelo Carotti
Journal:  Molecules       Date:  2018-01-27       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.